Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/17498666

Biochem. Pharmacol. 2007 Jul 15 74 2 191-201

Download in:

View as

General Info

PMID
17498666